In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020–2021: a multicenter study.

MLA

Galani, Irene, et al. “In Vitro Activities of Omadacycline, Eravacycline, Cefiderocol, Apramycin, and Comparator Antibiotics against Acinetobacter Baumannii Causing Bloodstream Infections in Greece, 2020–2021: A Multicenter Study.” European Journal of Clinical Microbiology & Infectious Diseases, vol. 42, no. 7, July 2023, pp. 843–52. EBSCOhost, https://doi.org/10.1007/s10096-023-04616-7.

APA

Galani, I., Papoutsaki, V., Karaiskos, I., Moustakas, N., Galani, L., Maraki, S., Mavromanolaki, V. E., Legga, O., Fountoulis, K., Platsouka, E. D., Giannopoulou, P., Papadogeorgaki, H., Damala, M., Chinou, E., Pasxali, A., Deliolanis, I., Vagiakou, H., Petinaki, E., Chli, A., & Vagdatli, E. (2023). In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020–2021: a multicenter study. European Journal of Clinical Microbiology & Infectious Diseases, 42(7), 843–852. https://doi.org/10.1007/s10096-023-04616-7

Chicago

Galani, Irene, Vassiliki Papoutsaki, Ilias Karaiskos, Nikolaos Moustakas, Lamprini Galani, Sofia Maraki, Viktoria Eirini Mavromanolaki, et al. 2023. “In Vitro Activities of Omadacycline, Eravacycline, Cefiderocol, Apramycin, and Comparator Antibiotics against Acinetobacter Baumannii Causing Bloodstream Infections in Greece, 2020–2021: A Multicenter Study.” European Journal of Clinical Microbiology & Infectious Diseases 42 (7): 843–52. doi:10.1007/s10096-023-04616-7.